Mercy Health - Paducah Medical Oncology and Hematology

Paducah, KY

Sorting 1 by

Accepting patients

MAXILUS

A Phase 3b, Open-label Study Evaluating the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) Initiated at Maximum Approved Dose in LR-MDS With IPSS-R Very Low-, Low-, or Intermediate-risk Who Require RBC Transfusions (MAXILUS)
Learn more
  • Erythroid Maturation Agent (EMA)
  • Red Blood Cell Stimulant
  • Phase 3